Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.38 USD | -1.06% | -0.12% | +1.82% |
06-01 | Delaware judge lets more than 70,000 Zantac lawsuits go forward | RE |
05-31 | Suave Brands Company LLC acquired ChapStick Brand of Haleon plc. | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an enterprise value anticipated at 3.26 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.82% | 38.12B | - | ||
+42.83% | 748B | C+ | ||
+34.11% | 598B | B | ||
-5.70% | 356B | C+ | ||
+18.06% | 325B | B- | ||
+4.63% | 283B | C+ | ||
+17.02% | 245B | B+ | ||
+9.26% | 211B | B- | ||
-4.21% | 209B | A+ | ||
+2.43% | 166B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HLN Stock
- HLN Stock
- Ratings Haleon plc